Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has reported beneficial ownership of 7.6% of M-tron Industries, Inc.'s common stock as of March 31, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 4.97% of Marketwise, Inc.'s Class A Stock as of March 31, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.7% of Mid Penn Bancorp Inc.'s common stock as of March 31, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing its beneficial ownership of Princeton Bancorp Inc. common stock as of March 31, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 6.0% of SmartFinancial Inc.'s common stock as of March 31, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 4.7% in Solid Biosciences Inc. as of March 31, 2026, holding 4,578,650 shares.

BlackRock, Inc. has reported beneficial ownership of 5.9% of StandardAero, Inc.'s common stock as of March 31, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 4.9% in Summit Midstream Corp's common stock as of March 31, 2026.

BlackRock, Inc. has reported a beneficial ownership of 4.8% in Telos Corp's common stock as of March 31, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of over 2.6 million shares, representing 5.02% of Voyager Technologies, Inc.'s common stock.

BlackRock, Inc. has reported a beneficial ownership of 4.8% in Xponential Fitness, Inc. Class A Stock as of March 31, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.2% of Alector, Inc.'s common stock as of March 31, 2026.

BlackRock, Inc. has disclosed a beneficial ownership of 6.4% in Baxter International Inc. as of March 31, 2026, holding over 33 million shares.

BlackRock Inc. has reported a 4.2% beneficial ownership in Candel Therapeutics Inc. as of March 31, 2026, holding over 3 million shares.

BlackRock, Inc. has reported beneficial ownership of 5.1% of Dianthus Therapeutics Inc.'s common stock as of March 31, 2026.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.0% of First Mid Bancshares, Inc. common stock as of March 31, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing beneficial ownership of 939,393 shares, representing 6.5% of the outstanding common stock of the iShares J.P. Morgan EM High Yield Bond ETF.

BlackRock, Inc. has disclosed a beneficial ownership of 5.6% in LSB Industries Inc. as of March 31, 2026.

BlackRock, Inc. has disclosed beneficial ownership of 804,944 shares, representing 6.5% of the outstanding common stock of Metropolitan Bank Holding Corp.

BlackRock Inc. has disclosed a beneficial ownership of 5.7% in Mirum Pharmaceuticals, Inc. as of March 31, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.4% of Credicorp Ltd.'s common stock as of March 31, 2026.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.9% of Golar LNG Limited's common stock as of March 31, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.2% of Nutrien Ltd.'s common stock as of March 31, 2026, holding over 24.8 million shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6,814,525 shares, representing 4.8% of the outstanding common stock of Niocorp Developments Ltd.

BlackRock, Inc. has disclosed beneficial ownership of 3,218,304 shares, representing 5.3% of the outstanding common stock of NICE LTD, as of March 31, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.2% of Urogen Pharma Ltd's common stock as of March 31, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 4.96% of Caledonia Mining Corporation PLC's common stock as of March 31, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.8% in Greenlight Capital Re Ltd's Class A Stock as of March 31, 2026.

BlackRock Inc. has disclosed a beneficial ownership of 8.0% of ADT Inc.'s common stock as of March 31, 2026, holding over 60.9 million shares.

BlackRock, Inc. has filed a Schedule 13G amendment, reporting zero beneficial ownership of common stock in Advanced Flower Capital Inc. as of March 31, 2026.